Feasibility of preemptive pharmacogenetic testing and improvement of medication treatment satisfaction among medically underserved patients is a research paper published in Clinical and Translational Science (2023). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCATS NIH HHS
Grant: UL1 TR001427
NHGRI NIH HHS
Grant: R01 HG011800
National Institutes of Health
Grant: 5R01HG011800-04
Preemptive pharmacogenetic testing in medically underserved populations
National Institutes of Health
Grant: 5UL1TR001427-08
Together: Transforming and Translating Discovery to Improve Health
FWCI
6.88
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords